Overview
Status
Active
Registry date
2022-09-01
Share capital
1,310,000.00 PLN
Registered address
ul. Gruszowa 47, 42-215 Częstochowa, Poland
Electronic delivery address
AE:PL-27913-34819-BEEVJ-25
Financials
Revenue history (in k)
Filing timeliness
2 of 4 financial statements were filed late (the longest delay 3 days for 2022).
- 202512/05/2026
- 202416/07/2025
- 202328/06/2024
- 202218/07/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations110 / 231
Top 48%
Results vs industry
Revenue
This companyUSD 1.17mMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 80.49kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 915.40kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 3.36mMedianUSD 118.27kAverageUSD 1.54m
Industry
- Manufacture of prepared animal feeds (10.9)
Authorized Representatives
Anna Harciarek Freus – Management Board Member
Grzegorz Harciarek – Vice President of the Management Board
Tomasz Harciarek – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Grzegorz Harciarekage 56 | 10,000 | $135,062.13 | 38.1679% |
Tomasz Harciarekage 53 | 16,000 | $216,099.41 | 61.0687% |
Others | 200 | $2,701.24 | 0.7634% |
Tomasz Harciarek and Grzegorz Harciarek hold a combined 99.2% – the ownership structure indicates family control.
Bank accounts
Registered as a VAT taxpayer on 2003-12-19.
71 1050 1227 1000 0023 1820 9463- 60 1050 1360 1000 0025 2081 8119
08 1020 1664 0000 3902 0782 2630
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 401.2KPLN 401,161 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,314$1,314 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,843$1,843 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,413$1,413 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
Last updated: 2026-05-12